ESGO.org

CERVICAL CANCER – POST-RECURRENCE SURVIVAL PREDICTION

Model is applicable for patients experiencing recurrence who previously underwent primary surgical treatment for early-stage disease (stage T1a–T2b).

Characteristics at the time of primary treatment

Characteristics of the disease recurrence

Model is developed on data from 528 patients who relapsed after primary treatment, that were obtained from SCCAN database containing 4,343 patients treated in 20 tertiary centres on 4 continents.

It has been evaluated by 10-fold cross-validation within the imputed data set. The resulting median C-index equals 0.701*